Theratechnologies Inc. (NASDAQ:THTX) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET
Company Participants
Elif McDonald - Head of Investor Relations
Paul Levesque - President and Chief Executive Officer
Philippe Dubuc - Chief Financial Officer
Christian Marsolais - Chief Medical Officer
John Leasure - Global Commercial Officer
Conference Call Participants
Carvey Leung - Cantor Fitzgerald
Andre Uddin - Research Capital
Endri Leno - National Bank
Operator
Good morning, ladies and gentlemen and thank you for standing by. Welcome to Theratechnologies Fourth Quarter Fiscal Year 2022 Earnings Call. We would like to remind everyone that all figures on this call are quoted in U.S. dollars. At this time, all participants are in a listen only mode. Following the presentation, we will conduct a question-and-answer session with analysts. Instructions will be provided at that [Technical Difficulty]
Elif McDonald
Hello?
Paul Levesque
Elif, it looks like the operator is no longer there.
Elif McDonald
The operator is gone.
Operator
Pardon the interruption. I apologize for that.
Elif McDonald
Okay. Oh, there you are.
Operator
We'll begin again. At this time all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session with analysts. Instructions will be provided at that time for you to queue up for questions. Following the analyst Q&A session, investors wish to submit a question, may do so by clicking on the Ask a Question Link on the webcast platform. [Operator Instructions] I would like to remind everyone that this conference call is being recorded today, February 28, 2023, at 08:30AM Eastern Time.
I will now turn the call over to Ms. Elif McDonald, Head of Investor Relations. Ms. McDonald, please go ahead.
Elif McDonald
Thank you, M.J. And good morning, everyone. On the call today will be our President and Chief Executive Officer, Mr. Paul Levesque; and Chief Financial Officer, Mr. Philippe Dubuc. During our Q&A session, we will be joined by Dr. Christian Marsolais, Chief Medical Officer; and Mr. John Leasure, our Global Commercial Officer.
Before we begin, I'd like to remind everyone that Theratechnologies' remarks today contains forward-looking statements containing its
current and future plan, expectations and intentions with respect to future events. Forward-looking statements are based on assumptions and there are risks that results obtained by the company may differ materially from those assumptions. As such, the company cannot guarantee that any forward-looking statements will materialize and you are cautioned not to place undue reliance on them. We refer current and potential investors to the forward-looking information and risk factors section of our management's discussion and analysis issued this morning and available on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Forward-looking statements represent Theratechnologies' expectations as of February 27, 2023.